J 2022

COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study

ARKADIUSZ, Dziedzic, Julien ISSA, Mohammad Salman HUSSAIN, Tanasiewicz MARTA, Wojtyczka ROBERT et. al.

Basic information

Original name

COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study

Authors

ARKADIUSZ, Dziedzic, Julien ISSA, Mohammad Salman HUSSAIN (356 India, belonging to the institution), Tanasiewicz MARTA, Wojtyczka ROBERT, Kubina ROBERT, Konwinska Marta DYSZKIEWICZ and Abanoub RIAD (818 Egypt, guarantor, belonging to the institution)

Edition

Frontiers in Public Health, LAUSANNE, FRONTIERS MEDIA SA, 2022, 2296-2565

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30304 Public and environmental health

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 5.200

RIV identification code

RIV/00216224:14110/22:00126335

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.3389/fpubh.2022.938067

UT WoS

000891406400001

Keywords in English

cross-sectional studies; COVID-19 vaccines; decision making; healthcare professionals; vaccination hesitancy; Poland

Tags

14110525, 14119612, 14119613, rivok

Tags

International impact, Reviewed
Změněno: 5/4/2023 08:17, Mgr. Tereza Miškechová

Abstract

V originále

Since healthcare professionals (HCPs) play a critical role in shaping their local communities' attitudes toward vaccines, HCPs' beliefs and attitudes toward vaccination are of vital importance for primary prevention strategies. The present study was designed as a cross-sectional survey-based study utilizing a self-administered questionnaire to collect data about COVID-19 vaccine booster hesitancy (VBH) among Polish HCPs and students of medical universities (MUSs). Out of the 443 included participants, 76.3% were females, 52.6% were HCPs, 31.8% were previously infected by SARS-CoV-2, and 69.3% had already received COVID-19 vaccine booster doses (VBD). Overall, 74.5% of the participants were willing to receive COVID-19 VBD, while 7.9 and 17.6% exhibited their hesitance and rejection, respectively. The most commonly found promoter for acceptance was protection of one's health (95.2%), followed by protection of family's health (81.8%) and protection of community's health (63.3%). Inferential statistics did not show a significant association between COVID-19 VBH and demographic variables, e.g., age and gender; however, the participants who had been previously infected by SARS-CoV-2 were significantly more inclined to reject the VBD. Protection from severe infection, community transmission, good safety profile, and favorable risk-benefit ratio were the significant determinants of the COVID-19 VBD acceptance and uptake. Fear of post-vaccination side effects was one of the key barriers for accepting COVID-19 VBD, which is consistent with the pre-existing literature. Public health campaigns need to highlight the postulated benefits of vaccines and the expected harms of skipping VBD.

Links

EF18_053/0016952, research and development project
Name: Postdoc2MUNI
EF19_073/0016943, research and development project
Name: Interní grantová agentura Masarykovy univerzity
MUNI/A/1402/2021, interní kód MU
Name: Prohlubování znalostí v oblasti zdravotních rizik a benefitů výživy, prostředí a životního stylu IV
Investor: Masaryk University
MUNI/IGA/1104/2021, interní kód MU
Name: COVID-19 Vaccines Safety Tracking in the Czech Republic (Acronym: CoVaST-CZ)
Investor: Masaryk University
Displayed: 5/11/2024 02:29